Hypertension | | | | | |
HT 4 | BPa | 324 (74) | 37 742 (91) | –17 | P<0.001 |
HT 5 | BP is ≤ 150/90 mmHga | 294 (67) | 32 238 (77) | –10 | P<0.001 |
Coronary heart disease | | | | | |
CHD 5 | BPa | 167 (86) | 11 978 (97) | –11 | P<0.001 |
CHD 6 | BP is ≤ 150/90 mmHgb | 161 (83) | 11 004 (89) | –6 | P = 0.005 |
CHD 7 | Total cholesterolb | 113 (68) | 11 339 (92) | –24 | P<0.001 |
CHD 8 | Total cholesterol ≤ 5mmol/lb | 110 (56) | 9459 (77) | –21 | P<0.001 |
CHD 11 | Patients with a history of myocardial infarction (diagnosed after 1 April 2003) currently treated with an ACE inhibitor or angiotensin II antagonistc | 11 (52) | 1523 (84) | –32 | P<0.001 |
CHD 12 | Record of influenza immunisation in the preceding 1 September–31 March | 152 (78) | 9890 (80) | –2 | P = 0.493 |
Stroke/TIA | | | | | |
STROKE 5 | BPb | 139 (82) | 5084 (96) | –14 | P<0.001 |
STROKE 6 | BP is ≤ 150/90 mmHgb | 130 (77) | 4621 (87) | –10 | P<0.001 |
STROKE 7 | Total cholesterolb | 92 (54) | 4708 (89) | –35 | P<0.001 |
STROKE 8 | Last total cholesterol ≤ 5mmol/lb | 73 (43) | 3746 (70) | –27 | P<0.001 |
STROKE 10 | Record of influenza immunisation in the preceding 1 September–31 March | 131 (78) | 3977 (75) | 3 | P = 0.494 |
Diabetes | | | | | |
DM 2 | BMIb | 81 (61) | 11 835 (92) | –31 | P<0.001 |
DM 5 | HbA1cb | 101 (74) | 12 085 (94) | –20 | P<0.001 |
DM 7 | Last HbA1c is ≤ 10b | 98 (72) | 11 371 (88) | –16 | P<0.001 |
DM 9 | Presence or absence of peripheral pulsesb | 53 (39) | 10 665 (83) | –46 | P<0.001 |
DM 10 | Neuropathy testingb | 51 (37) | 10 523 (82) | –45 | P<0.001 |
DM 11 | BPb,c | 115 (84) | 12 445 (97) | –13 | P<0.001 |
DM 12 | Last BP is ≤ 145/85 mmHg | 116 (85) | 10 085 (79) | 4 | P = 0.083 |
DM 16 | Total cholesterolb | 113 (83) | 12 062 (94) | –11 | P<0.001 |
DM 17 | Last total cholesterol ≤ 5mmol/lb | 96 (70) | 9967 (78) | –8 | P = 0.038 |
DM 18 | Record of influenza immunisation in the preceding 1 September–31 March | 113 (83) | 9855(77) | 6 | P = 0.116 |
DM 20 | Last HbA1c is ≤ 7.5b | 74 (54) | 8323 (65) | –11 | P = 0.010 |
DM 21 | Retinal screeningb | 53 (39) | 10 891 (85) | –46 | P<0.001 |
DM 22 | eGFR or serum creatinine testingb | 112 (82) | 12 141 (95) | –13 | P<0.001 |
Atrial fibrillation | | | | | |
AF 3 | Patients with AF currently treated with anticoagulation/anti-platelet therapy | 75 (76) | 3693 (91) | –15 | P<0.001 |
Heart failure | | | | | | |
HF 3 | Patients with a current diagnosis of HF due to LVD currently treated with ACE inhibitor or angiotensin receptor blockerc | 2 (100) | 1200 (83) | 17 | P = 0.527 |
Smoking | | | | | |
SMOKE 3 | CHD, stroke/TIA, HT, DM, COPD or asthma patients, whose notes record smoking statusb | 172 (82) | 64 256 (95) | –13 | P<0.001 |
SMOKE 4 | CHD, stroke/TIA, HT, DM, COPD or asthma patients, who smoke whose notes have record of smoking cessation advice/referral to specialist offeredb,c | 23 (48) | 11 247 (92) | –44 | P<0.001 |